1. Home
  2. VLO vs BMY Comparison

VLO vs BMY Comparison

Compare VLO & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valero Energy Corporation

VLO

Valero Energy Corporation

SELL

Current Price

$369.13

Market Cap

111.5B

Sector

Energy

ML Signal

SELL

Logo Bristol-Myers Squibb Company

BMY

Bristol-Myers Squibb Company

SELL

Current Price

$62.90

Market Cap

127.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VLO
BMY
Founded
1980
1887
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.5B
127.0B
IPO Year
1997
2006

Fundamental Metrics

Financial Performance
Metric
VLO
BMY
Price
$369.13
$62.90
Analyst Decision
Hold
Buy
Analyst Count
20
28
Target Price
★ $421.32
$65.25
AVG Volume (30 Days)
2.9M
★ 9.2M
Earning Date
10-22-2026
10-29-2026
Dividend Yield
1.30%
★ 4.00%
EPS Growth
N/A
★ 178.46
EPS
★ 40.29
3.98
Revenue
★ $122,687,000,000.00
$48,194,000,000.00
Revenue This Year
$41.12
$4.23
Revenue Next Year
N/A
N/A
P/E Ratio
★ $9.18
$15.82
Revenue Growth
N/A
★ N/A
52 Week Low
$159.90
$45.27
52 Week High
$461.52
$68.64

Technical Indicators

Market Signals
Indicator
VLO
BMY
Relative Strength Index (RSI) 43.50 54.01
Support Level $364.96 $59.94
Resistance Level $419.04 $63.47
Average True Range (ATR) 15.63 1.68
MACD -1.07 0.12
Stochastic Oscillator 46.27 53.70

Price Performance

Historical Comparison
VLO
BMY

About VLO Valero Energy Corporation

Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which can produce 1.2 billion gallons per year of renewable diesel.

About BMY Bristol-Myers Squibb Company

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: